In dilated cardiomyopathy, short-term administration of L-thyroxine (100 micrograms/ day) improves cardiac and exercise performance without changing the heart's adrenergic sensitivity. The aim of this study was to test the medium-term (3 months) efficacy of L-thyroxine (10 patients) compared with placebo (10 patients) and to find out whether later effects are obtainable.
Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy / P. Moruzzi, E. Doria, P. G. Agostoni. - In: THE AMERICAN JOURNAL OF MEDICINE. - ISSN 0002-9343. - 101:5(1996 Nov), pp. 461-7-467.
Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy
P. MoruzziPrimo
;P. G. AgostoniUltimo
1996
Abstract
In dilated cardiomyopathy, short-term administration of L-thyroxine (100 micrograms/ day) improves cardiac and exercise performance without changing the heart's adrenergic sensitivity. The aim of this study was to test the medium-term (3 months) efficacy of L-thyroxine (10 patients) compared with placebo (10 patients) and to find out whether later effects are obtainable.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
